GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (CHIX:0QFd) » Definitions » Accounts Payable

Moderna (CHIX:0QFD) Accounts Payable : €259 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Moderna Accounts Payable?

Moderna's Accounts Payable for the quarter that ended in Jun. 2024 was €259 Mil.

Moderna's quarterly Accounts Payable declined from Dec. 2023 (€477 Mil) to Mar. 2024 (€168 Mil) but then increased from Mar. 2024 (€168 Mil) to Jun. 2024 (€259 Mil).

Moderna's annual Accounts Payable increased from Dec. 2021 (€267 Mil) to Dec. 2022 (€460 Mil) and increased from Dec. 2022 (€460 Mil) to Dec. 2023 (€477 Mil).


Moderna Accounts Payable Historical Data

The historical data trend for Moderna's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna Accounts Payable Chart

Moderna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable
Get a 7-Day Free Trial 6.38 14.80 267.27 459.73 476.84

Moderna Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 286.13 462.88 476.84 168.36 259.19

Moderna Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Moderna Accounts Payable Related Terms

Thank you for viewing the detailed overview of Moderna's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Moderna Business Description

Address
200 Technology Square, Cambridge, MA, USA, 02139
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Moderna Headlines

No Headlines